Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ABBOTT LABORATORIES

(ABT)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/23/2021 07/26/2021 07/27/2021 07/28/2021 07/29/2021 Date
120.8(c) 119.52(c) 119.81(c) 120.52(c) 121.09(c) Last
4 736 348 4 955 054 5 631 002 3 796 137 3 917 240 Volume
+2.16% -1.06% +0.24% +0.59% +0.47% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 39 766 M - -
Net income 2021 5 967 M - -
Net Debt 2021 8 719 M - -
P/E ratio 2021 36,1x
Yield 2021 1,41%
Sales 2022 39 642 M - -
Net income 2022 6 564 M - -
Net Debt 2022 6 387 M - -
P/E ratio 2022 33,1x
Yield 2022 1,50%
Capitalization 215 B 215 B -
EV / Sales 2021 5,63x
EV / Sales 2022 5,59x
Nbr of Employees 109 000
Free-Float 89,0%
More Financials
Company
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Company focuses on cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition and medicine. It offers products,... 
More about the company
Ratings of Abbott Laboratories
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about ABBOTT LABORATORIES
09:01aNEW STUDY : Half of Americans Living with Diabetes May be Consuming Less Than th..
PR
07/27Global markets live: LVMH, Michelin, Tesla, Amazon, Activision...
07/23ABBOTT LABORATORIES : Jefferies & Co Adjusts Abbott Laboratories PT to $135 From..
MT
07/23ABBOTT LABORATORIES : JPMorgan Adjusts Abbott Laboratories PT to $135 From $122,..
MT
07/23ABBOTT LABORATORIES : Morgan Stanley Adjusts Abbott Laboratories PT to $136 From..
MT
07/23ABBOTT LABORATORIES : Raymond James Adjusts Price Target on Abbott Laboratories ..
MT
07/23ABBOTT LABORATORIES : Credit Suisse Raises Abbott Laboratories' PT to $130 from ..
MT
07/23ABBOTT LABORATORIES : UBS Adjusts Abbott Laboratories' PT to $131 From $127, Cit..
MT
07/23ANALYST RECOMMENDATIONS : Apple, Aviva, Biogen, Comerica Incorporated, Tesla...
07/22GLOBAL MARKETS LIVE : AT&T, American Airlines, Biogen, Netflix, ABB...
07/22ABBOTT LABORATORIES : 2Q 2021 Earnings Infographic
PU
07/22ABBOTT LABORATORIES : Reports Higher Second-Quarter Earnings, Topping Estimates ..
MT
07/22Today on Wall Street: Jobless claims rise again
07/22SECTOR UPDATE : Health Care Stocks Slightly Higher in Premarket Thursday
MT
07/22Abbott Laboratories 2Q Sales Rise, Beat Analysts' Expectations
DJ
More news
News in other languages on ABBOTT LABORATORIES
07/27MADRID STOCK EXCHANGE : Las empresas en acción
07/27EN DIRECT DES MARCHES : LVMH, Christian Dior, Dassault Systèmes, Michelin, Ed..
07/27AVIS D'ANALYSTES DU JOUR : LVMH, Michelin, Faurecia, ABB, Sika, UBS, Deutsche Po..
07/27STOCK MARKET PARIS : Les entreprises à la manťuvre
07/23MADRID STOCK EXCHANGE : La moral sigue en pie
More news
Analyst Recommendations on ABBOTT LABORATORIES
More recommendations
Stock Trading Strategies
ABBOTT LABORATORIES - 01/20
Close to a key resistance level
BUY
More Stock Trading Analysis
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | MarketScreener
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 121,09 $
Average target price 128,81 $
Spread / Average Target 6,38%
EPS Revisions
Managers and Directors
Robert B. Ford President, CEO, Chief Operating Officer & Director
Robert Emmett Funck Chief Financial Officer & Executive Vice President
Miles D. White Executive Chairman
Sabina Ewing Chief Investment Officer, VP-Business & Technology
Roxanne Schuh Austin Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ABBOTT LABORATORIES10.07%214 142
MEDTRONIC PLC11.42%175 406
BECTON, DICKINSON AND COMPANY1.30%73 717
SARTORIUS STEDIM BIOTECH61.47%51 173
HOYA CORPORATION8.86%50 531
ALIGN TECHNOLOGY, INC.16.37%49 213